Detalhe da pesquisa
1.
Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway.
Semin Cancer Biol
; 83: 177-196, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877761
2.
Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies.
Saudi Pharm J
; 30(2): 138-149, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35528855
3.
ChCl: Gly (DESs) Promote Environmentally Benign Synthesis of Xanthene Derivatives and Their Antitubercular Activity.
Molecules
; 26(12)2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208536
4.
Vision of bacterial ghosts as drug carriers mandates accepting the effect of cell membrane on drug loading.
Drug Dev Ind Pharm
; 46(10): 1716-1725, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893682
5.
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and ß-Catenin and Akt activation.
Mol Cancer
; 16(1): 14, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28103884
6.
Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Stem Cells
; 34(12): 2799-2813, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502039
7.
Synthesis of new spirooxindole-pyrrolothiazole derivatives: Anti-cancer activity and molecular docking.
Bioorg Med Chem
; 25(4): 1514-1523, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126436
8.
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
J Enzyme Inhib Med Chem
; 32(1): 600-613, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173708
9.
Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
J Enzyme Inhib Med Chem
; 32(1): 935-944, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28718672
10.
Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo[3,2-a]benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation.
J Enzyme Inhib Med Chem
; 32(1): 986-991, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726519
11.
Target ß-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides.
Bioorg Med Chem Lett
; 26(7): 1664-70, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944615
12.
Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
Int J Mol Sci
; 17(8)2016 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27483243
13.
Targeting Cancer Stem Cells with Novel 4-(4-Substituted phenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thiones.
Molecules
; 21(12)2016 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999374
14.
Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide.
Bioorg Med Chem Lett
; 25(1): 83-7, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25466196
15.
Lead Optimization of 2-Cyclohexyl-N-[(Z)-(3-methoxyphenyl/3-hydroxyphenyl) methylidene]hydrazinecarbothioamides for Targeting the HER-2 Overexpressed Breast Cancer Cell Line SKBr-3.
Molecules
; 20(10): 18246-63, 2015 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457700
16.
Synthesis and anti-Candidal activity of N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl carbonyl) hydrazinecarbothioamide.
Bioorg Med Chem Lett
; 24(5): 1299-302, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24513049
17.
Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation.
PLoS One
; 19(4): e0298326, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625872
18.
Embryonic signature in breast cancers; Pluripotency roots of cancer stem cells.
Saudi Pharm J
; 21(2): 229-32, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23960839
19.
Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy.
J Adv Res
; 50: 177-192, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307019
20.
Erratum to: Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and ß-Catenin and Akt activation.
Mol Cancer
; 16(1): 69, 2017 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28340593